(Q40968228)

25 September 2017

1 reference

title

New pharmaceutical approaches to the treatment of cystic fibrosis (English)

1 reference

25 September 2017

0 references

Delaney SJ

1

1 reference

25 September 2017

Wainwright BJ

series ordinal

2

1 reference

25 September 2017

language of work or name

English

0 references

publication date

1 April 1996

1 reference

25 September 2017

1 reference

25 September 2017

volume

2

1 reference

25 September 2017

issue

4

1 reference

25 September 2017

page(s)

392-393

1 reference

Molecular mechanisms of CFTR chloride channel dysfunction in cystic fibrosis

25 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1038%2FNM0496-392

The amino-terminal portion of CFTR forms a regulated Cl- channel.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNM0496-392

Glycerol reverses the misfolding phenotype of the most common cystic fibrosis mutation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNM0496-392

Modulation of the ionic milieu of the airway in health and disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNM0496-392

Transfer of genes to humans: early lessons and obstacles to success

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNM0496-392

7 January 2021

https://api.crossref.org/works/10.1038%2FNM0496-392

1 reference

7 January 2021

Aminoglycoside antibiotics restore CFTR function by overcoming premature stop mutations

1 reference

https://api.crossref.org/works/10.1038%2FNM0496-392

7 January 2021

Phosphatase inhibitors activate normal and defective CFTR chloride channels

1 reference

https://api.crossref.org/works/10.1038%2FNM0496-392

7 January 2021

CFTR as a cAMP-dependent regulator of sodium channels

1 reference

https://api.crossref.org/works/10.1038%2FNM0496-392

7 January 2021

CFTR regulates outwardly rectifying chloride channels through an autocrine mechanism involving ATP

1 reference

https://api.crossref.org/works/10.1038%2FNM0496-392

7 January 2021

A pilot study of aerosolized amiloride for the treatment of lung disease in cystic fibrosis

1 reference

https://api.crossref.org/works/10.1038%2FNM0496-392

7 January 2021

Generation and characterization of a delta F508 cystic fibrosis mouse model.

1 reference

https://api.crossref.org/works/10.1038%2FNM0496-392

7 January 2021

A mouse model for the delta F508 allele of cystic fibrosis.

1 reference

https://api.crossref.org/works/10.1038%2FNM0496-392

7 January 2021

Cystic fibrosis mice carrying the missense mutation G551D replicate human genotype-phenotype correlations.

1 reference

https://api.crossref.org/works/10.1038%2FNM0496-392

7 January 2021

Identifiers

DOI

10.1038/NM0496-392

1 reference

25 September 2017

1 reference